Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

LYG-409

  Cat. No.:  DC67326   Featured
Chemical Structure
3053857-55-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86 21 58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
LYG-409 is an orally active degrader of GSPT1, demonstrating significant efficacy against acute myeloid leukemia and prostate cancer in vivo, with tumor growth inhibition (TGI) rates of 94.34% and 104.49%, respectively. In vitro, LYG-409 effectively inhibits KG-1 cells by degrading GSPT1, exhibiting an IC50 of 9.50 nM and a DC50 of 7.87 nM.
Cas No.: 3053857-55-6
Chemical Name: LYG-409
SMILES: O=C1N(CC2=C1C=CC(CNC(C3=CC4=C(OC3)C=CC(OC(F)(F)F)=C4)=O)=C2)C5CCC(NC5=O)=O
Formula: C25H20F3N3O6
M.Wt: 515.44
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Cat. No. Product name Field of application
DC60948 NEK7 degrader (Compound 17) NEK7 degrader-1 is a NEK7 molecular glue degrader with a DC50 of 9  nM. NEK7 degrader-1 dose-dependently inhibits caspase-1 activity and IL-Ιβ release in macrophages in response to NLRP3 inflammasome activation. NEK7 degrader-1 can be used for autoinflammatory and autoimmune disorders like multiple sclerosis, neurodegeneraive diseases like Alzheimer's disease and cardiovascular and melabolic disorders like pericarditis and Type 2 diabetes research.
DC68076 BG-BRD4-P07
DC68075 BRU-SHP2-P06
DC68074 LLY-ESR1-P05
DC68073 AST-AR-P04
DC68072 NOV-EP001
DC68071 JHU-MDM2-P03
DC68070 CAS-FAK-P02
DC68069 MDA-S24-P01
DC68068 TB-008
X